Author | Publication year | Study period | Region/Country | Study design | Population description | HTR status | Adherence threshold (%) | Adherence measure | Observation period | Quality assessment |
---|---|---|---|---|---|---|---|---|---|---|
Aloisi MS [41] | 2002 | 1997–1999 | Italy | Cohort | HIV-infected subjects who had never received antiretroviral therapy | DU | 100 | SR | 6 months | Moderate |
Avery AK [42] | 2013 | 2008–2011 | USA | Cross- sectional | Participants who were previously diagnosed HIV+ | HL | 90 | SR | 1 week | High |
Biello KB [43] | 2016 | 2012 | Latin America | Cross- sectional | Men who have sex with men who reported being paid for sex with another man in the past year | SW | 100 | SR | 1 month | Moderate |
Bijker R [44] | 2017 | 2007–2013 | Asia | Cohort | HIV-infected adults starting first-line ART | DU | 95 | SR | 6 months | High |
Braitstein P [45] | 2006 | 1996–2000 | Canada | Cohort | Individuals used triple combination ART as their first HIV therapy and had documented HCV serology | DU | 95 | PR | 1 year | High |
Cohn SE [46] | 2008 | 2002–2005 | USA | Cohort | HIV-infected women between 20 and 34 weeks’ gestation | DU | 100 | SR | 4 days or 3 months | Moderate |
Cohn SE [47] | 2011 | 1997–1999 | USA | Cross- sectional | HIV-infected subjects without prior Mycobacterium avium complex (MAC) and with documented immune reconstitution | DU | 100 | SR | 2 days | High |
de Boni RB [48] | 2016 | 2012–2013 | Argentina, Brazil, Chile, Honduras, Mexico, and Peru | Cross- sectional | Individuals receiving care at HIV clinics | DU | 100 | SR | 1 week | High |
de Jong BC [49] | 2005 | 2001 | USA | Cross- sectional | Patients within a public health care system for HIV/AIDS | DU | 100 | SR | 4 weeks | High |
Duff PK [50] | 2017 | 2014–2017 | Canada | Cohort | Women living with HIV | DU | 95 | SR | 3 to 4 weeks | High |
Gebo KA [51] | 2003 | 1999–2000 | USA | Cross- sectional | Consecutive HIV-infected patients taking at least 1 antiretroviral medication | DU | 90 | SR | 2 weeks | Moderate |
Gordillo V [52] | 1999 | 1997–1998 | Spain | Cross- sectional | HIV-infected patients who were on treatment with antiretroviral drugs | DU | 90 | SR and pill count | 1 week | High |
Hicks PL [53] | 2007 | 2003 | USA | Cross- sectional | HIV patients on HAART in primary care | DU | 95 | SR | 2 weeks | Moderate |
Jin H [54] | 2018 | 2013–2017 | USA | Cross- sectional | HIV-positive men who have sex with men who had biologically confirmed, recent methamphetamine use | HL | 90 | SR | 1 month | Moderate |
Johnson MO [55] | 2003 | 2000–2002 | USA | Cross- sectional | HIV-positive adults taking ART | DU, HL | 90 | SR | 3 days | Moderate |
Joseph B [56] | 2015 | 1996–2012 | Canada | Cohort | HIV-infected people who use illicit drugs in a setting of universal no-cost HIV/AIDS treatment | HL, DU, SW | 95 | PR | 6 months | High |
King RM [57] | 2012 | 2007–2009 | USA | Cross- sectional | Persons living with HIV/AIDS who smoke | DU | 100 | SR | 4 days | Moderate |
Krusi A [58] | 2010 | 1996–2007 | Canada | Cohort | HIV-positive injection drug users | DU | 95 | PR | 6 months | High |
Mohanned H [59] | 2004 | 1999–2001 | USA | Cohort | Convenience sample of HIV-infected subjects seen at outpatient HIV clinics | DU | 100 | SR | 1 week | High |
O’Neil CR [60] | 2012 | 2007–2010 | Canada | Cohort | HIV-positive persons who have accessed antiretroviral therapy | DU | 95 | PR | 1 year | High |
Palepu A [61] | 2004 | 1997–2002 | Canada | Cohort | Participants who were HIV-infected, naive to HAART and who were prescribed treatment | DU | 100 | PR | 6 months | High |
Roux P [62] | 2011 | 2006–2008 | France | Cohort | HIV/HCV coinfected patients on ART | DU | 100 | SR | 4 days | Moderate |
Shannon K [63] | 2005 | 2002–2004 | Canada | Cohort | HIV-infected persons | DU | 95 | PR | 6 months | Moderate |
Sharpe TT [64] | 2004 | 1997–2000 | USA | Cross- sectional | HIV-infected women | DU | 100 | SR | not reported | Moderate |
Stone VE [65] | 2001 | 1993–1995 | USA | Cross- sectional | Women living with HIV | DU | 100 | SR | 3 days | Moderate |
Teixeira C [66] | 2013 | 2006–2008 | Brazil | Cohort | HIV-positive patients with no previous ART | DU | 95 | SR | 1 month | High |
Tucker JS [67] | 2003 | 1997–1998 | USA | Cohort | People with known HIV infection and made at least one patient care visit | DU | 100 | SR | 1 week | High |
Turner BJ [68] | 2000 | 1993–1997 | USA | Cohort | Postpartum HIV-infected women | DU | 80 | PR | > 2 months | High |
Wilson TE [69] | 2002 | 1998–1999 | USA | Cohort | HIV-positive women | DU | 95 | SR | 6 months | Moderate |